Citius Pharma Overview
- Founded
-
2007

- Status
-
Public
- Employees
-
15

- Stock Symbol
-
CTXR

- Investments
-
3
- Share Price
-
$1.17
- (As of Friday Closing)
Citius Pharma General Information
Description
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.
Contact Information
- 11 Commerce Drive
- First Floor
- Cranford, NJ 07016
- United States
Citius Pharma Timeline
Citius Pharma Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.17 | $1.19 | $0.83 - $2.35 | $174M | 146M | 1.14M | -$0.19 |
Citius Pharma Financials Summary
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 30-Sep-2021 | FY 2020 30-Sep-2020 | FY 2019 30-Sep-2019 |
---|---|---|---|---|
EV | 197,385 | 182,337 | 50,567 | 17,506 |
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (27,430) | (23,141) | (17,448) | (15,597) |
Net Income | (27,571) | (23,054) | (17,548) | (15,562) |
Total Assets | 127,786 | 142,429 | 43,774 | 36,746 |
Total Debt | 769 | 855 | 1,352 | 173 |
Citius Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Citius Pharma Comparisons
Industry
Citius Pharma Competitors (47)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Acorda Therapeutics | Formerly VC-backed | Ardsley, NY | 000 | 00000 | 000000&0 | |
000000 | Formerly VC-backed | San Francisco, CA | 0 | 0000 | 000000000000 | 0000 |
00000000 | Corporation | Berkeley Heights, NJ | 00 | 000.00 | 000000&0 | |
00000000 000000000 | Corporation | Watertown, MA | 000 | 00000 | 000000000 | 00000 |
0000000 0000000000 | Formerly PE-Backed | Solana Beach, CA | 00 | 000000&0 |
Citius Pharma Executive Team (9)
Citius Pharma Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Carol Webb | Citius Pharma | Board Member | 000 0000 |
Eugene Holuka MD | Citius Pharma | Board Member | 000 0000 |
Howard Safir | Citius Pharma | Board Member | 000 0000 |
Leonard Mazur | Self | Chief Executive Officer & Chairman | 000 0000 |
Myron Holubiak | Citius Pharma | Board Member & Vice Chairman | 000 0000 |
Citius Pharma Signals
Citius Pharma Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Citius Pharma Investments & Acquisitions (3)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00. 00000 (00 | 07-Sep-2021 | 000000000 | 0000 | Buildings and Property | 00000 000 |
0000000-00000 | 04-Apr-2016 | 0000000000 | Biotechnology | 0000000 0 | |
Trail One | 12-Sep-2014 | Merger/Acquisition | 00.000 | Automotive |